These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 4151048

  • 21. ACTH and alpha-MSH: cardiovascular and antiarrhythmic properties.
    Lindner E, Schölkens B.
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):19-23. PubMed ID: 4367710
    [No Abstract] [Full Text] [Related]

  • 22. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
    Rao TS, Seth SD, Manchanda SC, Nayar U.
    Arch Int Pharmacodyn Ther; 1989 Mar; 302():128-44. PubMed ID: 2636814
    [Abstract] [Full Text] [Related]

  • 23. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG, Tay J.
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK, Patterson E, Lucchesi BR.
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [Abstract] [Full Text] [Related]

  • 27. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ, Lomas TE, Counsell RE, Lucchesi BR.
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [Abstract] [Full Text] [Related]

  • 28. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT, Gluckman MI.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract] [Full Text] [Related]

  • 29. Centrogenic cardiac arrhythmia induced by aconitine: a new "model" for screening of anti-arrhythmic drugs.
    Sinha JN, Shamsi MA, Kohli RP, Bhargava KP.
    Jpn J Pharmacol; 1971 Dec; 21(6):699-706. PubMed ID: 4401179
    [No Abstract] [Full Text] [Related]

  • 30. Antiarrhythmic effects of tricyclic antidepressant drugs in ouabain-induced arrhythmias in the dog.
    Wilkerson RD.
    J Pharmacol Exp Ther; 1978 Jun; 205(3):666-74. PubMed ID: 660536
    [No Abstract] [Full Text] [Related]

  • 31. [Antiarrhythmic properties of fubromegan on different models of experimental cardiac arrhythmia].
    Samvelian VM, L'vov MV.
    Farmakol Toksikol; 1970 Jun; 33(3):309-13. PubMed ID: 4393833
    [No Abstract] [Full Text] [Related]

  • 32. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B, Förster W.
    Pharmazie; 1976 Jun; 31(9):635-9. PubMed ID: 1019213
    [No Abstract] [Full Text] [Related]

  • 33. [The antiarrhythmic activity of the trimecain ammonium derivative in myocardial ischemia].
    Kostin IaV, Blinov DS, Moiseeva IIa.
    Eksp Klin Farmakol; 2003 Jun; 66(3):29-31. PubMed ID: 12924229
    [Abstract] [Full Text] [Related]

  • 34. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D, Wauters E.
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract] [Full Text] [Related]

  • 35. Beta-adrenergic blockade and antiarrhythmic activity of (-)- and (+)-propranolol.
    Flórez J, Pomar JL, Malpartida F.
    Rev Esp Fisiol; 1969 Dec; 25(4):287-92. PubMed ID: 4401670
    [No Abstract] [Full Text] [Related]

  • 36. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ, Reynolds RD.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K, Grünheid K.
    Pharmazie; 1976 Mar; 31(1):33-6. PubMed ID: 1257276
    [No Abstract] [Full Text] [Related]

  • 40. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML, Stone CA, Wenger HC, Evans R, Lagerquist B, O'Malley T.
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.